Site-directed Mutagenesis Using DNA Polymerase
Site-directed Mutagenesis Using DNA Polymerase
Site-directed Mutagenesis Using DNA Polymerase
Conduct quantitative and qualitative immunoassays like ELISA and binding assays with these white, 96-well immuno plates.
The Genedata Biopharma Platform is first-in-class enterprise software that automates R&D workflows and drives scientific innovation. It delivers analytics- and AI-driven insights that help bring better life-saving therapies to patients faster and more cost-effectively.
Pkg of 1, 10% polyacrylamide gel, 12 + 2-well, 45 µl, 13.3 x 8.7 cm (W x L), for use with Criterion and Criterion Dodeca cells
Pkg of 1, 15% polyacrylamide gel, 12 + 2-well, 45 µl, 13.3 x 8.7 cm (W x L), for use with Criterion and Criterion Dodeca cells
Octet® SAX biosensors are high precision streptavidin biosensors that were specifically developed and qualified for applications in drug discovery and quality control labs that have stringent requirements for assay precision and robustness in quantitation and binding kinetics characterization assays.
SR7500DC pushes the limits of detection and sensitivity in label-free interaction analysis.
Explore the new technologies and techniques that promise to provide confidence and reproducibility in results
New results suggest the MammaTyper test could predict the likelihood of complete pathologic remission
Non-invasive, cell-free pre-natal DNA testing to be performed on QIAGEN’s GeneReader NGS System
A blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests
Institut Curie is one of an increasing number of major European cancer centers to become a co-validation partner for the new NGS-based MammaPrint BluePrint Kit
Watch industry leading scientists discuss the very latest developments in cancer research, made possible with digital PCR technology